Release week 2026-08-19
⭐ This week's notable releases
1 novel sequence, 7 confidently wrong. Highlight: DNA-directed RNA polymerase II subunit GRINL1A.
| PDB | Protein | Flags | Why it matters |
|---|---|---|---|
|
|
DNA-directed RNA polymerase II subunit GRINL1A | novel · 100% confidently wrong | Genuinely unseen sequence (0% identity to anything AlphaFold trained on) — and AlphaFold got the fold wrong despite high confidence. |
|
|
WAS/WASL-interacting protein family member 1 | confidently wrong | A close pre-cutoff homolog existed (97% identity to 2IFS_1) yet AlphaFold confidently missed the fold. |
|
|
Zinc finger protein Aiolos | confidently wrong | A close pre-cutoff homolog existed (91% identity to 2MA7_1) yet AlphaFold confidently missed the fold. |
|
|
Zinc finger protein Aiolos | confidently wrong | A close pre-cutoff homolog existed (91% identity to 2MA7_1) yet AlphaFold confidently missed the fold. |
|
|
Zinc finger protein Aiolos | confidently wrong | A close pre-cutoff homolog existed (91% identity to 2MA7_1) yet AlphaFold confidently missed the fold. |
|
|
Zinc finger protein Aiolos | confidently wrong | A close pre-cutoff homolog existed (91% identity to 2MA7_1) yet AlphaFold confidently missed the fold. |
Zoomed into the red "confidently wrong" box above (pLDDT ≥ 70, TM < 0.5) — the structures AlphaFold got confidently wrong.
The worst offenders ranked, one row per protein (AlphaFold has one model per sequence, so repeat depositions are collapsed — “×N” marks how many structures of that protein exist; the worst is shown). Each row joins what AlphaFold claimed (blue, pLDDT/100) to what the experiment showed (red, TM-score) — the longer the bar, the bigger the miss. Hover a dot to preview its Cα-deviation ribbon; click to open the full entry.
How to read this
Every point is one experimental protein structure. The horizontal axis is AlphaFold's own confidence in its prediction (mean pLDDT, 0–100). The vertical axis is how well that blind prediction actually matches the experiment (TM-score, 0–1; above 0.5 means the same fold, above 0.9 near-identical). Marker size grows with the FRAUD score (confidence-weighted error).
Cutoff: the shaded red box is the "confidently wrong" zone — AlphaFold was confident (mean pLDDT above 70) yet the fold is wrong (TM-score below 0.5). A predictor that had truly solved folding would leave that box empty.
Take-home: 7 of 131 structures (5.3%) are confidently wrong; median TM-score is 0.952.
Read moreShow less — how each metric is calculated
TM-score: how similar the two 3D shapes are overall, 0–1 (a random pair scores ~0.17, an identical fold ~1). Length-normalised so large and small proteins compare fairly. TM = (1/L) Σᵢ 1/(1 + (dᵢ/d₀)²) — dᵢ is the gap between the i-th aligned Cα atoms after best-fit superposition, and d₀ = 1.24(L−15)^⅓ − 1.8 sets the distance scale for length L. Ref: Zhang & Skolnick, Proteins 2004 doi:10.1002/prot.20264; computed with TM-align, doi:10.1093/nar/gki524.
pLDDT: AlphaFold's own confidence in each residue, 0–100 (higher = surer). It is the model predicting its own accuracy before ever seeing the experiment. We plot the per-structure mean. pLDDT = (1/N) Σᵢ pLDDTᵢ, where pLDDTᵢ is the network's confidence output for residue i.
FRAUD score: the headline number — how wrong the prediction was, weighted by how confident AlphaFold was, so a big error it was sure about counts most. FRAUD = (1/N) Σᵢ (pLDDTᵢ/100) · min(Δᵢ,15)/15, where Δᵢ is residue i's Cα distance from the experiment (Å) after superposition, capped at 15 Å. Runs 0 (perfect) to 1.
Novelty: how little AlphaFold had to go on — 100 minus the highest sequence identity between this protein and any structure released before the 2018-04-30 training cutoff. High = genuinely unseen (100% = nothing similar was ever in the training set). novelty = 100 − maxₚ identity(s, p) over pre-cutoff PDB chains p, with identity = 100 × (matching aligned residues)/(alignment length), from an MMseqs2 search.
Homology: the point colour. High novelty (above 70%) flags the sequence as novel (amber) — AlphaFold had no close template; otherwise a pre-cutoff homolog existed (blue) it could have learned the fold from. novel ⇔ novelty > 70%.
What the metrics mean
TM-score (0–1): overall fold match — above 0.5 is the same fold, above 0.9 near-identical. Cα-RMSD (Å): average backbone distance after best-fit superposition — lower is better (under 2 Å is excellent). lDDT (0–1): local accuracy measured without superposition — above 0.8 is good. Each bar counts how many structures fall in that range.
Take-home: median TM-score 0.952 — most predictions match the experimental fold well, with a long tail that do not.
Read moreShow less — how each metric is calculated
TM-score: overall shape match, 0–1 (above 0.5 = same fold, above 0.9 near-identical), length-normalised. TM = (1/L) Σᵢ 1/(1 + (dᵢ/d₀)²) with dᵢ the aligned-Cα gap after superposition and d₀ = 1.24(L−15)^⅓ − 1.8. Ref: Zhang & Skolnick, Proteins 2004 doi:10.1002/prot.20264.
Cα-RMSD: the average straight-line distance between matching backbone Cα atoms once the two structures are best-fit superposed (Å; lower is better, under ~2 Å excellent). RMSD = √( (1/N) Σᵢ |Pᵢ − (R·Qᵢ + t)|² ), with Pᵢ/Qᵢ the experimental/model Cα coordinates and R,t the rotation and translation from Kabsch superposition.
lDDT: local accuracy with no superposition — the fraction of short-range inter-residue distances the model reproduces, so it is not fooled by a single wrongly-placed domain. lDDT = (1/N) Σᵢ ¼ Σ_t 1[ |d_exp − d_model| < t ] over thresholds t ∈ {0.5, 1, 2, 4} Å and all residue pairs within 15 Å.
Trend over time
The blue line is the mean TM-score of the structures by their deposit month; the red bars count how many were confidently wrong. Binning by deposit date (rather than by when we processed them) gives an even timeline, tracking whether AlphaFold's accuracy on newly-deposited structures is holding steady, improving, or slipping as the PDB keeps growing. Months with fewer than 5 structures are omitted so each point is a meaningful average. A dashed trend line is drawn only if the change over time is statistically significant.
Read moreShow less — how each metric is calculated
Mean TM-score: the month's average shape-match score. TM̄ = (1/M) Σ TM over the M structures deposited that month.
Trend line: a monotonic-trend test over the monthly means — Mann-Kendall (Kendall's τ) for significance, with a robust Theil-Sen slope for the line. Rank-based, so it tolerates the skewed TM distribution and noisy low-count months. Shown only when p < 0.05; otherwise a note reports that no significant trend was found.
Confidently wrong: the count that were both confident and wrong. count( mean pLDDT > 70 AND TM < 0.5 ).
Matched structures
| PDB | UniProt | Protein | Method | Å | Deposited | Novelty % | pLDDT | TM | lDDT | GDT_TS | RMSD | FRAUD | Flag |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30DR_1 | O75154 | Rab11 family-interacting protein 3 | EM | 10.00 | 2026-04-21 | 0.00 | 93.67 | 0.56 | 0.97 | 0.00 | 44.92 | 0.94 | ok |
| 11OA_A | Q9Y6K1 | DNA (cytosine-5)-methyltransferase 3A | EM | 5.04 | 2026-03-05 | 0.70 | 93.58 | 0.67 | 0.82 | 6.02 | 15.84 | 0.74 | ok |
| 9YGT_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 3.42 | 2025-09-29 | 0.00 | 81.08 | 0.62 | 0.79 | 1.80 | 21.55 | 0.72 | ok |
| 11OI_A | Q9Y6K1 | DNA (cytosine-5)-methyltransferase 3A | EM | 3.66 | 2026-03-06 | 0.50 | 93.74 | 0.61 | 0.82 | 9.37 | 14.67 | 0.68 | ok |
| 9I7X_C | Q9HB29 | Interleukin-1 receptor-like 2 | EM | 3.27 | 2025-02-03 | 68.80 | 84.71 | 0.64 | 0.86 | 5.57 | 16.75 | 0.68 | ok |
| 9YBL_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 3.44 | 2025-09-17 | 0.00 | 81.51 | 0.66 | 0.77 | 4.16 | 18.38 | 0.66 | ok |
| 28JC_M | P0CAP2 | DNA-directed RNA polymerase II subunit GRI | EM | 2.94 | 2026-02-03 | 100.00 novel | 87.88 | 0.39 | 0.83 | 4.55 | 15.40 | 0.65 | wrong |
| 9S9X_B | O43516 | WAS/WASL-interacting protein family member | NMR | — | 2025-08-06 | 2.80 | 70.24 | 0.30 | 0.54 | 2.83 | 16.06 | 0.57 | wrong |
| 9V0E_I | Q9UKT9 | Zinc finger protein Aiolos | EM | 3.51 | 2025-05-17 | 8.90 | 80.89 | 0.45 | 0.64 | 24.09 | 7.36 | 0.36 | wrong |
| 9V09_I | Q9UKT9 | Zinc finger protein Aiolos | EM | 3.25 | 2025-05-17 | 8.90 | 80.89 | 0.46 | 0.75 | 30.45 | 6.69 | 0.32 | wrong |
| 9V0C_I | Q9UKT9 | Zinc finger protein Aiolos | EM | 3.27 | 2025-05-17 | 8.90 | 80.89 | 0.47 | 0.76 | 29.55 | 6.69 | 0.32 | wrong |
| 9UUQ_I | Q9UKT9 | Zinc finger protein Aiolos | EM | 3.41 | 2025-05-07 | 8.90 | 80.89 | 0.47 | 0.76 | 29.55 | 6.65 | 0.32 | wrong |
| 9S9X_A | P42768 | Actin nucleation-promoting factor WAS | NMR | — | 2025-08-06 | 47.20 | 91.66 | 0.64 | 0.61 | 33.33 | 6.25 | 0.31 | ok |
| 9NVB_D | P13535 | Myosin-8 peptide | X-ray | 2.76 | 2025-03-20 | — | 88.22 | 0.35 | 0.62 | 38.33 | 5.50 | 0.29 | wrong |
| 9UUQ_R | P62877 | E3 ubiquitin-protein ligase RBX1, N-termin | EM | 3.41 | 2025-05-07 | — | 79.25 | 0.71 | — | — | — | 0.23 | ok |
| 9V0C_R | P62877 | E3 ubiquitin-protein ligase RBX1, N-termin | EM | 3.27 | 2025-05-17 | — | 79.25 | 0.71 | — | — | — | 0.23 | ok |
| 9V09_R | P62877 | E3 ubiquitin-protein ligase RBX1, N-termin | EM | 3.25 | 2025-05-17 | — | 79.25 | 0.71 | — | — | — | 0.23 | ok |
| 9V0E_R | P62877 | E3 ubiquitin-protein ligase RBX1, N-termin | EM | 3.51 | 2025-05-17 | — | 79.25 | 0.71 | — | — | — | 0.23 | ok |
| 9Z03_A | Q96P20 | NACHT, LRR and PYD domains-containing prot | EM | 3.03 | 2025-10-30 | — | 81.06 | 0.73 | — | — | — | 0.22 | ok |
| 31BG_A | P09471 | Guanine nucleotide-binding protein G(o) su | EM | 3.47 | 2026-05-22 | — | 94.50 | 0.78 | — | — | — | 0.21 | ok |
| 31ZN_A | Q9UHR5 | SAP30-binding protein | EM | 2.90 | 2026-06-30 | — | 64.88 | 0.70 | — | — | — | 0.19 | ok |
| 28JC_L | P53803 | DNA-directed RNA polymerases I, II, and II | EM | 2.94 | 2026-02-03 | — | 85.75 | 0.79 | — | — | — | 0.18 | ok |
| 9V0E_A | Q13619 | Cullin-4A | EM | 3.51 | 2025-05-17 | — | 88.56 | 0.83 | — | — | — | 0.15 | ok |
| 9V0C_A | Q13619 | Cullin-4A | EM | 3.27 | 2025-05-17 | — | 88.56 | 0.84 | — | — | — | 0.15 | ok |
| 9UUQ_A | Q13619 | Cullin-4A | EM | 3.41 | 2025-05-07 | — | 88.56 | 0.84 | — | — | — | 0.15 | ok |
| 9V09_A | Q13619 | Cullin-4A | EM | 3.25 | 2025-05-17 | — | 88.56 | 0.84 | — | — | — | 0.14 | ok |
| 9TLU_A | Q07817 | Bcl-2-like protein 1 | X-ray | 2.99 | 2025-12-11 | — | 72.50 | 0.82 | — | — | — | 0.13 | ok |
| 30DR_s | Q9NP97 | Dynein light chain roadblock-type 1 | EM | 10.00 | 2026-04-21 | — | 93.19 | 0.87 | — | — | — | 0.12 | ok |
| 28JC_I | P36954 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 85.75 | 0.86 | — | — | — | 0.12 | ok |
| 9UUQ_B | Q16531 | DNA damage-binding protein 1 | EM | 3.41 | 2025-05-07 | — | 92.00 | 0.87 | — | — | — | 0.12 | ok |
| 9V0C_B | Q16531 | DNA damage-binding protein 1 | EM | 3.27 | 2025-05-17 | — | 92.00 | 0.87 | — | — | — | 0.12 | ok |
| 9V09_B | Q16531 | DNA damage-binding protein 1 | EM | 3.25 | 2025-05-17 | — | 92.00 | 0.87 | — | — | — | 0.12 | ok |
| 9V0E_B | Q16531 | DNA damage-binding protein 1 | EM | 3.51 | 2025-05-17 | — | 92.00 | 0.87 | — | — | — | 0.12 | ok |
| 9UUQ_U | P62979 | Ubiquitin | EM | 3.41 | 2025-05-07 | — | 89.56 | 0.87 | — | — | — | 0.12 | ok |
| 9V0E_U | P62979 | Ubiquitin | EM | 3.51 | 2025-05-17 | — | 89.56 | 0.87 | — | — | — | 0.12 | ok |
| 9V0C_U | P62979 | Ubiquitin | EM | 3.27 | 2025-05-17 | — | 89.56 | 0.88 | — | — | — | 0.11 | ok |
| 9V09_U | P62979 | Ubiquitin | EM | 3.25 | 2025-05-17 | — | 89.56 | 0.88 | — | — | — | 0.11 | ok |
| 9Y7A_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 4.39 | 2025-09-09 | — | 77.50 | 0.87 | — | — | — | 0.10 | ok |
| 28JC_D | O15514 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 91.25 | 0.90 | — | — | — | 0.09 | ok |
| 9YBP_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 4.00 | 2025-09-17 | — | 77.50 | 0.88 | — | — | — | 0.09 | ok |
| 9YC8_B | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 4.02 | 2025-09-18 | — | 77.50 | 0.89 | — | — | — | 0.09 | ok |
| 31BG_C | P59768 | Guanine nucleotide-binding protein G(I)/G( | EM | 3.47 | 2026-05-22 | — | 89.56 | 0.91 | — | — | — | 0.08 | ok |
| 28JC_N | Q8IXW5 | Putative RNA polymerase II subunit B1 CTD | EM | 2.94 | 2026-02-03 | — | 64.25 | 0.88 | — | — | — | 0.08 | ok |
| 28JC_J | P62875 | DNA-directed RNA polymerases I, II, and II | EM | 2.94 | 2026-02-03 | — | 92.94 | 0.91 | — | — | — | 0.08 | ok |
| 9UUQ_N | Q15843 | NEDD8 | EM | 3.41 | 2025-05-07 | — | 89.94 | 0.91 | — | — | — | 0.08 | ok |
| 28JC_G | P62487 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 95.62 | 0.92 | — | — | — | 0.08 | ok |
| 9V0C_N | Q15843 | NEDD8 | EM | 3.27 | 2025-05-17 | — | 89.94 | 0.91 | — | — | — | 0.08 | ok |
| 9V0E_N | Q15843 | NEDD8 | EM | 3.51 | 2025-05-17 | — | 89.94 | 0.92 | — | — | — | 0.07 | ok |
| 9Q2X_A | P01116 | Isoform 2B of GTPase KRas | NMR | — | 2025-08-15 | — | 91.50 | 0.92 | — | — | — | 0.07 | ok |
| 9V09_N | Q15843 | NEDD8 | EM | 3.25 | 2025-05-17 | — | 89.94 | 0.92 | — | — | — | 0.07 | ok |
| 9Q30_A | P01116 | Isoform 2B of GTPase KRas | NMR | — | 2025-08-15 | — | 91.50 | 0.93 | — | — | — | 0.06 | ok |
| 9Q2Z_A | P01116 | Isoform 2B of GTPase KRas | NMR | — | 2025-08-15 | — | 91.50 | 0.94 | — | — | — | 0.06 | ok |
| 9V09_C | Q96SW2 | Protein cereblon | EM | 3.25 | 2025-05-17 | — | 86.62 | 0.93 | — | — | — | 0.06 | ok |
| 9UUQ_C | Q96SW2 | Protein cereblon | EM | 3.41 | 2025-05-07 | — | 86.62 | 0.94 | — | — | — | 0.06 | ok |
| 30DR_j | O43237 | Cytoplasmic dynein 1 light intermediate ch | EM | 10.00 | 2026-04-21 | — | 61.50 | 0.91 | — | — | — | 0.06 | ok |
| 9Z8I_A | Q8N8S7 | Protein enabled homolog | NMR | — | 2025-11-18 | — | 70.62 | 0.92 | — | — | — | 0.05 | ok |
| 9V09_D | P51668 | Ubiquitin-conjugating enzyme E2 D1 | EM | 3.25 | 2025-05-17 | — | 96.38 | 0.95 | — | — | — | 0.05 | ok |
| 9S9U_A | Q9Y653 | Adhesion G-protein coupled receptor G1 | X-ray | 1.92 | 2025-08-06 | — | 77.88 | 0.93 | — | — | — | 0.05 | ok |
| 9V0E_D | P51668 | Ubiquitin-conjugating enzyme E2 D1 | EM | 3.51 | 2025-05-17 | — | 96.38 | 0.95 | — | — | — | 0.05 | ok |
| 28JC_F | P61218 | DNA-directed RNA polymerases I, II, and II | EM | 2.94 | 2026-02-03 | — | 78.44 | 0.94 | — | — | — | 0.05 | ok |
| 9UUQ_D | P51668 | Ubiquitin-conjugating enzyme E2 D1 | EM | 3.41 | 2025-05-07 | — | 96.38 | 0.95 | — | — | — | 0.05 | ok |
| 31BG_R | P35462 | Green fluorescent protein,D(3) dopamine re | EM | 3.47 | 2026-05-22 | — | 75.38 | 0.94 | — | — | — | 0.05 | ok |
| 9V0E_C | Q96SW2 | Protein cereblon | EM | 3.51 | 2025-05-17 | — | 86.62 | 0.95 | — | — | — | 0.05 | ok |
| 9XB7_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.36 | 2025-10-23 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 9XBZ_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.34 | 2025-10-24 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 9XF8_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.26 | 2025-10-28 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 9XAM_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.23 | 2025-10-22 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 9V0C_C | Q96SW2 | Protein cereblon | EM | 3.27 | 2025-05-17 | — | 86.62 | 0.95 | — | — | — | 0.04 | ok |
| 9XF7_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.34 | 2025-10-28 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 9V0C_D | P51668 | Ubiquitin-conjugating enzyme E2 D1 | EM | 3.27 | 2025-05-17 | — | 96.38 | 0.96 | — | — | — | 0.04 | ok |
| 9I7X_B | Q9NZH8 | Interleukin-36 gamma | EM | 3.27 | 2025-02-03 | — | 90.50 | 0.95 | — | — | — | 0.04 | ok |
| 9XB3_A | P01116 | Isoform 2B of GTPase KRas | X-ray | 1.32 | 2025-10-23 | — | 91.50 | 0.95 | — | — | — | 0.04 | ok |
| 30DR_g | Q13409 | Isoform 2C of Cytoplasmic dynein 1 interme | EM | 10.00 | 2026-04-21 | — | 72.69 | 0.94 | — | — | — | 0.04 | ok |
| 28JC_H | P52434 | DNA-directed RNA polymerases I, II, and II | EM | 2.94 | 2026-02-03 | — | 84.25 | 0.95 | — | — | — | 0.04 | ok |
| 9YAG_B | B4E328 | HLA class II histocompatibility antigen, D | X-ray | 3.20 | 2025-09-15 | — | 81.81 | 0.95 | — | — | — | 0.04 | ok |
| 9WBV_A | Q8IWV8 | E3 ubiquitin-protein ligase UBR2 | EM | 3.13 | 2025-08-15 | — | 84.62 | 0.96 | — | — | — | 0.03 | ok |
| 9XJ8_A | P07900 | Heat shock protein HSP 90-alpha | EM | 4.09 | 2025-11-04 | — | 85.19 | 0.96 | — | — | — | 0.03 | ok |
| 36NB_A | P43699 | Homeobox protein Nkx-2.1 | X-ray | 3.26 | 2026-06-19 | — | 56.31 | 0.94 | — | — | — | 0.03 | ok |
| 28JC_E | P19388 | DNA-directed RNA polymerases I, II, and II | EM | 2.94 | 2026-02-03 | — | 93.06 | 0.97 | — | — | — | 0.03 | ok |
| 9Y7I_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 3.73 | 2025-09-10 | — | 77.50 | 0.96 | — | — | — | 0.03 | ok |
| 9S7Z_A | Q86U10 | 60 kDa lysophospholipase | X-ray | 2.73 | 2025-08-05 | — | 89.75 | 0.96 | — | — | — | 0.03 | ok |
| 9I7X_A | Q9NPH3 | Interleukin-1 receptor accessory protein | EM | 3.27 | 2025-02-03 | — | 86.06 | 0.96 | — | — | — | 0.03 | ok |
| 9SA6_A | P02649 | Apolipoprotein E | X-ray | 1.89 | 2025-08-07 | — | 75.50 | 0.96 | — | — | — | 0.03 | ok |
| 11NZ_A | Q9Y6K1 | DNA (cytosine-5)-methyltransferase 3A | EM | 4.19 | 2026-03-05 | — | 72.94 | 0.96 | — | — | — | 0.03 | ok |
| 9SA3_A | P02649 | Apolipoprotein E | X-ray | 2.19 | 2025-08-07 | — | 75.50 | 0.96 | — | — | — | 0.03 | ok |
| 9YCD_A | Q5S007 | Leucine-rich repeat serine/threonine-prote | EM | 3.63 | 2025-09-18 | — | 77.50 | 0.96 | — | — | — | 0.03 | ok |
| 9S93_A | P02766 | Transthyretin | X-ray | 1.94 | 2025-08-06 | — | 88.00 | 0.97 | — | — | — | 0.03 | ok |
| 9TZ2_A | Q8NBK3 | Formylglycine-generating enzyme | X-ray | 1.15 | 2026-01-21 | — | 83.56 | 0.97 | — | — | — | 0.03 | ok |
| 9S94_A | P02766 | Transthyretin | X-ray | 1.70 | 2025-08-06 | — | 88.00 | 0.97 | — | — | — | 0.03 | ok |
| 9YAF_B | B4E328 | HLA class II histocompatibility antigen, D | X-ray | 3.25 | 2025-09-15 | — | 81.81 | 0.97 | — | — | — | 0.03 | ok |
| 9YAF_A | P01909 | HLA class II histocompatibility antigen, D | X-ray | 3.25 | 2025-09-15 | — | 87.94 | 0.97 | — | — | — | 0.03 | ok |
| 9NVB_A | Q8NB12 | Histone-lysine N-methyltransferase SMYD1 | X-ray | 2.76 | 2025-03-20 | — | 93.00 | 0.97 | — | — | — | 0.03 | ok |
| 9S91_A | P02766 | Transthyretin | X-ray | 1.70 | 2025-08-06 | — | 88.00 | 0.97 | — | — | — | 0.03 | ok |
| 11ZJ_A | Q9UKV8 | Protein argonaute-2 | EM | 3.29 | 2026-03-19 | — | 92.38 | 0.97 | — | — | — | 0.03 | ok |
| 9YAG_A | P01909 | HLA class II histocompatibility antigen, D | X-ray | 3.20 | 2025-09-15 | — | 87.94 | 0.97 | — | — | — | 0.03 | ok |
| 9S95_A | P02766 | Transthyretin | X-ray | 1.55 | 2025-08-06 | — | 88.00 | 0.97 | — | — | — | 0.03 | ok |
| 11OH_A | Q9Y6K1 | DNA (cytosine-5)-methyltransferase 3A | EM | 3.58 | 2026-03-06 | — | 72.94 | 0.97 | — | — | — | 0.02 | ok |
| 9UYB_A | Q7Z7L7 | Protein zer-1 homolog | X-ray | 2.20 | 2025-05-15 | — | 90.81 | 0.97 | — | — | — | 0.02 | ok |
| 9WBW_A | Q8IWV7 | E3 ubiquitin-protein ligase UBR1 | EM | 3.44 | 2025-08-15 | — | 84.69 | 0.97 | — | — | — | 0.02 | ok |
| 9TZ1_A | Q8NBK3 | Formylglycine-generating enzyme | X-ray | 1.50 | 2026-01-21 | — | 83.56 | 0.97 | — | — | — | 0.02 | ok |
| 9Q3L_A | P07550 | Beta-2 adrenergic receptor | EM | 2.50 | 2025-08-18 | — | 79.12 | 0.97 | — | — | — | 0.02 | ok |
| 9I85_A | Q07820 | Induced myeloid leukemia cell differentiat | X-ray | 1.90 | 2025-02-04 | — | 63.62 | 0.97 | — | — | — | 0.02 | ok |
| 28JC_K | P52435 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 94.25 | 0.98 | — | — | — | 0.02 | ok |
| 9WB2_A | P03372 | Estrogen receptor | X-ray | 1.95 | 2025-08-13 | — | 66.44 | 0.97 | — | — | — | 0.02 | ok |
| 9S77_A | P68400 | Casein kinase II subunit alpha | X-ray | 1.79 | 2025-08-04 | — | 88.94 | 0.98 | — | — | — | 0.02 | ok |
| 28JC_A | P24928 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 76.00 | 0.98 | — | — | — | 0.02 | ok |
| 9S7Y_A | Q86U10 | 60 kDa lysophospholipase | X-ray | 2.50 | 2025-08-05 | — | 89.75 | 0.98 | — | — | — | 0.02 | ok |
| 31ZN_B | P21127 | Isoform 7 of Cyclin-dependent kinase 11B | EM | 2.90 | 2026-06-30 | — | 64.56 | 0.98 | — | — | — | 0.01 | ok |
| 28JC_C | P19387 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 92.06 | 0.98 | — | — | — | 0.01 | ok |
| 31ZN_C | Q96S94 | Cyclin-L2 | EM | 2.90 | 2026-06-30 | — | 69.12 | 0.98 | — | — | — | 0.01 | ok |
| 28JC_B | P30876 | DNA-directed RNA polymerase II subunit RPB | EM | 2.94 | 2026-02-03 | — | 89.94 | 0.99 | — | — | — | 0.01 | ok |
| 9TLV_B | Q07820 | Induced myeloid leukemia cell differentiat | X-ray | 2.00 | 2025-12-11 | — | 63.62 | 0.98 | — | — | — | 0.01 | ok |
| 12UX_A | A6NK06 | Cis-aconitate decarboxylase | X-ray | 1.32 | 2026-04-20 | — | 95.19 | 0.99 | — | — | — | 0.01 | ok |
| 9S76_A | P68400 | Casein kinase II subunit alpha | X-ray | 1.73 | 2025-08-04 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9TLW_B | Q07820 | Induced myeloid leukemia cell differentiat | X-ray | 2.80 | 2025-12-11 | — | 63.62 | 0.99 | — | — | — | 0.01 | ok |
| 28IZ_A | Q9NPC2 | Potassium channel subfamily K member 9 | EM | 2.83 | 2026-02-02 | — | 75.94 | 0.99 | — | — | — | 0.01 | ok |
| 12VD_A | A6NK06 | Cis-aconitate decarboxylase | X-ray | 1.22 | 2026-04-20 | — | 95.19 | 0.99 | — | — | — | 0.01 | ok |
| 12VT_A | A6NK06 | Cis-aconitate decarboxylase | X-ray | 1.62 | 2026-04-20 | — | 95.19 | 0.99 | — | — | — | 0.01 | ok |
| 12VW_A | A6NK06 | Cis-aconitate decarboxylase | X-ray | 1.46 | 2026-04-20 | — | 95.19 | 0.99 | — | — | — | 0.01 | ok |
| 12VQ_A | A6NK06 | Cis-aconitate decarboxylase | X-ray | 1.42 | 2026-04-20 | — | 95.19 | 0.99 | — | — | — | 0.01 | ok |
| 9S7I_A | P68400 | Casein kinase II subunit alpha | X-ray | 2.11 | 2025-08-04 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9S93_B | P02766 | Transthyretin | X-ray | 1.94 | 2025-08-06 | — | 88.00 | 0.99 | — | — | — | 0.01 | ok |
| 9S9Y_A | P68400 | Casein kinase II subunit alpha | X-ray | 1.86 | 2025-08-07 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9S8J_A | P68400 | Casein kinase II subunit alpha | X-ray | 2.48 | 2025-08-05 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9S7A_A | P68400 | Casein kinase II subunit alpha | X-ray | 2.03 | 2025-08-04 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9T2X_A | P19784 | Casein kinase II subunit alpha' | X-ray | 1.10 | 2025-10-24 | — | 94.12 | 0.99 | — | — | — | 0.01 | ok |
| 9S7H_A | P68400 | Casein kinase II subunit alpha | X-ray | 2.09 | 2025-08-04 | — | 88.94 | 0.99 | — | — | — | 0.01 | ok |
| 9S7U_A | Q04609 | Glutamate carboxypeptidase 2 | X-ray | 1.54 | 2025-08-05 | — | 93.81 | 0.99 | — | — | — | 0.01 | ok |
| 9T0U_A | P19784 | Casein kinase II subunit alpha' | X-ray | 1.07 | 2025-10-20 | — | 94.12 | 0.99 | — | — | — | 0.01 | ok |
| 9XJ8_E | Q14318 | Isoform 2 of Peptidyl-prolyl cis-trans iso | EM | 4.09 | 2025-11-04 | — | 80.62 | 0.99 | — | — | — | 0.00 | ok |
| 31DC_A | Q8NBK3 | Formylglycine-generating enzyme | X-ray | 2.30 | 2026-05-27 | — | 83.56 | 1.00 | — | — | — | 0.00 | ok |
Click a column header to sort. FRAUD = confidence-weighted error; a structure is flagged confidently wrong when mean pLDDT > 70 yet TM-score < 0.5.